A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), ...
A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be ...
Glycyrrhizin, a natural licorice compound, significantly reduces intestinal inflammation and cell death, offering fresh hope ...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results